New insights into gout epidemiology

Current Opinion in Rheumatology

Volumn 18, Issue 2, 2006, Pages 199-203

  Mikuls, Ted R ^a   Saag, Kenneth G ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Cardiovascular disease; Comorbidity; Epidemiology; Gout; Hyperuricemia; NHANES; Serum urate

Indexed keywords

ALLOPURINOL; ATENOLOL; ATORVASTATIN; COLCHICINE; LOSARTAN; PROBENECID; SULFINPYRAZONE; URATE;

CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; GOUT; HEALTH CARE QUALITY; HUMAN; HYPERURICEMIA; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL;

CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; FOOD HABITS; GOUT; HUMANS; MALE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; URIC ACID;

EID: 33646703978     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000209435.89720.7c     Document Type: Review

References (29)

1. Aromdee E, Michet C, Crowson C, et al. Epidemiology of gout: is the incidence rising? J Rheumatol 2002; 29:2403-2406.
2. Wallace K, Riedel A, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004; 31:1582-1587. Epidemiologic study using administrative data and providing estimates suggesting a rising prevalence of gout in this US population.
3. Mikuls T, Farrar J, Bilker W, et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005; 64:267-272. Utilized a large national electronic medical record to provide updated estimates of gout incidence and prevalence.
4. Choi H, Atkinson K, Karlson E, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350:1093-1103.
5. Choi H, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005; 52:283-289. Interesting analysis from NHANES largely reproducing associations seen in [4] with respect to uric acid instead of gout cases.
6. •] again confirming similar alcohol consumption/gout associations as observed in the Health Professionals Follow-Up Study [7].
7. Choi H, Atkinson K, Karlson E, et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363:1277-1281.
8. Gibson T, Rodgers A, Simmonds H, Toseland P. Beer drinking and its effect on uric acid. Br J Rheumatol 1984; 23:203-209.
9. Choi H, Atkinson K, Karlson E, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men. Arch Intern Med 2005; 165:742-748.
10. Johnson R, Rideout B. Uric acid and diet: insights into the epidemic of cardiovascular disease. N Engl J Med 2004; 350:1071-1073. Important review of a topic of rising interest and growing strength of evidence.
11. Dessein P, Shipton E, Stanwix A, et al. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 2000; 59:539-543.
12. Fam A. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002; 29:1350-1355.
13. Baker J, Krishnan E, Chen L, Schumacher H. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005; 118:816-826. Excellent review summarizing relevant literature on this controversial topic.
14. Fang J, Alderman M. Serum uric acid and cardiovascular mortality: NHANES I epidemiologic follow-up study, 1971-1992. JAMA 2000; 283:2404-2410.
15. Brand F, McGee D, Kannel W, et al. Hyperuricemia as a risk factor of coronary artery disease: the Framingham Study. Am J Epidemiol 1985; 121:11-18.
16. Madsen T, Muhlestein J, Carlquist J, et al. Serum uric acid independently predicts mortality in patients with significant angiographically defined coronary artery disease. Am J Nephrol 2005; 25:45-49. Further evidence of an association of serum urate and cardiovascular disease, particularly among those at highest existing risk.
17. Short R, Johnson R, Tuttle K. Uric acid, microalbuminuria and cardiovascular events in high-risk patients. Am J Nephrol 2005; 25:36-44.
18. Hakoda M, Masunari N, Yamada M, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors. J Rheumatol 2005; 32:906-912.
19. Johnson R, Kang D, Feig D, et al. Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease. Hypertension 2003; 41:1183-1190.
20. Khosla U, Zharikov S, Finch J, et al. Hyperuricemia induces endothelial dysfunction. Kidney International 2005; 67:1739-1742. Excellent physiologic study providing added biological plausibility for an association of rising uric acid with vascular disease.
21. Vasquez-Vivar J, Santos A, Junqueira V, Augusto O. Peroxynitrite-mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albumin-thiyl and uric acid derived free radicals. Biochem J 1996; 314:869-876.
22. Leyva F, Anker S, Swan J, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997; 18:858-865.
23. Sundstrom J, Sullivan L, D'Agostino R, et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45:28-33. Further evidence of a relationship between serum urate and hypertension.
24. Athyros V, Elisaf M, Papageorgiou A, et al., GREACE Study Collaborative Group. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary artery disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis 2004; 43:589-599.
25. Hoieggen A, Alderman M, Kjeldsen S, et al., Life Study Group: the impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 65:1041-1049.
26. Mikuls T, MacLean C, Olivieri J, et al. Quality of care indicators for gout management. Arthritis Rheum 2004; 50:937-943.
27. •] and demonstrated compliance to allopurinol therapy in only about half of patients identified with gout.
28. Mikuls T, Farrar J, Bilker W, et al. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology 2005; 44:1038-1042. One-quarter to one-half of all patients eligible for at least one validated quality-of-care indicator [26] were subject to possible allopurinol prescribing errors.
29. Neogi T, Hunter DJ, Chaisson CE, et al. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2005 (Epub ahead of print). Unique Internet-based study also confirming poor quality of gout care in the general medical community.